拔管前吸气肌无力的靶向评估:危重通气患者多个观察性队列的个体数据汇总分析
本研究汇总多个观察性队列的个体数据,纳入494例接受有创机械通气的成人ICU患者,其中458例有拔管结局,72例(16%)发生拔管失败(定义为拔管后48小时内再插管或死亡)。评估的神经肌肉指标包括最大吸气压(MIP)、最大呼气压(MEP)、咳嗽峰流速(PCF)和MRC评分。总体人群中MIP≤30 cmH₂O仅呈临界相关(OR 1.94,95% CI 0.98-3.84,p=0.06)。在通气超过5天的患者中,MIP≤30 cmH₂O者拔管失败率为33%,MIP>30 cmH₂O者为14%,校正后OR 3.52(95% CI 1.37-9.03,p=0.009)。MEP、PCF和MRC未显示显著校正关联。
要点
- 机械通气超过5天的患者中,MIP≤30 cmH₂O者拔管失败率为33%,MIP>30 cmH₂O者为14%,校正OR 3.52(95% CI 1.37-9.03,p=0.009)。
- 总体人群中MIP≤30 cmH₂O与拔管失败仅呈临界相关(24% vs 14%;OR 1.94,95% CI 0.98-3.84,p=0.06),提示在未经选择人群中常规使用价值有限。
- MEP≤50 cmH₂O、PCF≤60 L/min、MRC<48/60在调整后均未显示与拔管失败的显著关联。
- 本研究纳入494例患者,458例有拔管结局,72例(16%)发生拔管失败,定义为拔管后48小时内再插管或死亡。
- 临床启示:神经肌肉评估应靶向用于机械通气时间较长、神经肌肉无力更可能影响脱机的患者,而非对所有拔管前患者常规使用。
适用人群与场景
- 成人ICU接受有创机械通气的患者,来自多个观察性队列,共494例患者,其中458例有拔管结局。
- 适宜靶向评估的场景为机械通气时间超过5天的患者,即在神经肌肉无力更可能导致脱机失败的人群中使用。
诊断标准与关键阈值
- 拔管失败定义为拔管后48小时内再插管或死亡。
- 预设阈值:MIP≤30 cmH₂O、MEP≤50 cmH₂O、PCF≤60 L/min、MRC<48/60。
- MIP的可用数据为230例,MEP为124例,PCF为156例,MRC评分为252例。
处置流程与药物剂量
- 原文未提供拔管前评估的具体操作流程或药物剂量推荐。
- 原文提示在机械通气超过5天的患者中,应关注MIP≤30 cmH₂O作为拔管失败风险增高的信号。
- 原文未提及拔管前决策的具体阈值以外的处理建议。
红旗征与不能漏的情况
- 机械通气超过5天且MIP≤30 cmH₂O的患者,拔管失败率达33%,应在拔管前警惕再插管或48小时内死亡的风险。
研究设计与关键结果
- 研究类型:多个观察性队列的个体患者数据汇总分析,共494例患者,458例有拔管结局。
- 主要结局:拔管失败,定义为拔管后48小时内再插管或死亡,发生率为16%(72/458)。
- 总体人群中,MIP≤30 cmH₂O组拔管失败率为24%,MIP>30 cmH₂O组为14%,OR 1.94(95% CI 0.98-3.84,p=0.06),仅呈临界统计学意义。
- 在机械通气超过5天的患者中,MIP≤30 cmH₂O组拔管失败率为33%,MIP>30 cmH₂O组为14%,校正OR 3.52(95% CI 1.37-9.03,p=0.009)。
- MEP≤50 cmH₂O、PCF≤60 L/min、MRC<48/60在调整后均未显示与拔管失败的显著关联。
证据类型、等级与局限
- 证据类型:多个观察性队列的个体患者数据汇总分析(pooled individual patient data analysis of multiple observational cohorts)。
- 原文未提供明确的证据等级或推荐强度。
- 局限:原文未提及具体局限,但观察性设计本身存在残余混杂可能;各神经肌肉指标的可用样本量不一致(MIP 230例、MEP 124例、PCF 156例、MRC 252例)。
对床旁实践的改变
- 不改变对未经选择的拔管前人群常规进行MEP、PCF或MRC等神经肌肉评估的做法,因为这些指标在总体人群中未显示显著预测价值。
- 对于机械通气超过5天的患者,可考虑将MIP≤30 cmH₂O作为拔管失败风险增高的警示信号,但不应单独作为拔管决策的唯一依据。
- 避免对所有拔管前患者普遍依赖单项神经肌肉测试;靶向使用可能比系统使用更具临床相关性。
- 原文未提及基于该结论的具体操作流程或干预措施。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Bedside neuromuscular tests are commonly proposed to assess readiness for extubation in critically ill patients. However, when used in unselected populations, their ability to predict clinically relevant outcomes such as extubation failure has been inconsistent. A more targeted use of these tests, restricted to patients in whom neuromuscular weakness is more likely to contribute to weaning failure, may improve their clinical relevance.
METHODS: We conducted a pooled individual patient data analysis of multiple observational cohorts including adult ICU patients receiving invasive mechanical ventilation. The primary outcome was extubation failure, defined as reintubation or death within 48 h after extubation. Available neuromuscular assessments included maximal inspiratory pressure (MIP), maximal expiratory pressure (MEP), peak cough flow (PCF), and Medical Research Council (MRC) sum score. Prespecified thresholds were MIP ≤ 30 cmH₂O, MEP ≤ 50 cmH₂O, PCF ≤ 60 L/min, and MRC < 48/60. Associations with extubation failure were assessed in the overall population and according to prior mechanical ventilation duration.
RESULTS: Among 494 included patients, 458 had an available extubation outcome and 72 (16%) experienced extubation failure. MIP was available in 230 patients, MEP in 124, PCF in 156, and MRC score in 252. In the overall population, MIP ≤ 30 cmH₂O showed only a borderline association with extubation failure (24% vs. 14%; OR 1.94, 95% CI 0.98 to 3.84; p = 0.06). In patients ventilated for more than 5 days, extubation failure occurred in 33% with MIP ≤ 30 cmH₂O versus 14% with MIP > 30 cmH₂O. After adjustment, MIP ≤ 30 cmH₂O remained associated with extubation failure (adjusted OR 3.52, 95% CI 1.37 to 9.03; p = 0.009). No significant adjusted association was observed for MEP, PCF, or MRC.
CONCLUSIONS: Neuromuscular tests may have limited prognostic value when applied broadly before extubation. Low MIP appears more informative after prolonged mechanical ventilation, supporting a targeted rather than systematic use of respiratory neuromuscular assessment before extubation.
参考来源
- Medrinal, Machefert, Dubois, et al. Toward targeted assessment of inspiratory muscle weakness before extubation: a pooled individual patient data analysis from multiple observational cohorts in critically ill ventilated patients. Crit Care. 2026. PMID: 42902295. doi:10.1186/s13054-026-06305-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。